Alexion Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 144 U.S.-traded ETFs. ALXN has around 18.4M shares in the U.S. ETF market. The largest ETF holder of ALXN is the SPDR S&P 500 ETF Trust (SPY), with approximately 2.44M shares. Investors may also find of interest that the ETF with the largest allocation to ALXN stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 4.73%. On average, U.S. ETFs allocate 0.46% of ALXN to their portfolios.
Additionally, ALXN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALXN as a holding is the ProShares UltraPro QQQ (TQQQ), with a return of 37.00%.